Clinical Trial Update: Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, biodistribution, radiation dosimetry, and tumor imaging potential of [131I]-SGMIB Anti-HER2 VHH1 in healthy volunteers and brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [131I]-SGMIB Anti-HER2 VHH1 (131I-labeled SGMIB-conjugated anti-HER2 VHH1)

Snippet

Sponsor: Precirix | Conditions: Healthy Volunteers, Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-07-18